Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



In silico characterization of Melittin from Apis cerana indica and evaluation of melittin intron for transgene expression in mammalian cells

Kevin Kumar Vijayakumar, Abisheik Rajandran, Sandhya Lumumba, Shakila Harshavardhan.




Abstract
Cited by 0 Articles

Bee venom is a colourless acidic liquid and can cause an anaphylactic reaction in higher doses. However, the therapeutic potential is enormous in a lower concentration, including anti-cancer, anti-microbial, anti-inflammatory, and antioxidant properties. Bee venom contains very few pharmacologically vital substances, and melittin is the principal component besides phospholipase A2, histamine, hyaluronidase, catecholamine, and serotonin. Melittin has demonstrated a range of therapeutic benefits in preclinical cell culture and animal models, including anti-cancer, anti-bacterial, anti-protozoan, and immunomodulatory properties. In the present study, we investigated the physicochemical composition, protein secondary structure, and antigenicity of the melittin peptide from Apis cerana indica through in silico approach and investigated the influence of melittin intron for transgene expression in the mammalian expression host system. From our study, we found that the mature melittin peptide from A. cerana indica is highly unstable, basic, and cationic in nature and the melittin intron has no positive effect on the transient expression of an exogenous gene in HEK-293 and CHO-K1 cell line.

Key words: Bee venom, Melittin, In-Silico, intron, transgene expression, Mammalian expression system.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.